Spots Global Cancer Trial Database for Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Official Title: Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Study ID: NCT00471120
Interventions
Study Description
Brief Summary: This study aims at developing an accurate, simple, and cost-effective method for screening and early detection of uterine cancers
Detailed Description: The present study aims at developing an accurate, simple and cost-effective method for screening and early detection of uterine cancers in women using novel inventions and biotechnology methods for collection and assay of uterine cells. Results of P2X7 assays using tissues obtained from women with known uterine cancer and from women with histologically normal endometrium will be compared. These data will also serve as basis for future studies to test the predictive value of the method in population-based studies.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Arkansas, Little Rock, Arkansas, United States
University Hospital CASE Medical Center, Cleveland, Ohio, United States
University of Texas, Dallas, Texas, United States
University of Texas, Galveston, Texas, United States
Eastern Virginia Medical School, Norfolk, Virginia, United States
Contact Details
Name: Jay Pinkerton, MD
Affiliation: University Hospitals Cleveland Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
